T1000	Negation 276 279	not
E1000	Negation:T1000 Scope:T1001
T1001	Span 276 339	not be cut enabling subsequent PCR amplification and vice versa
T1002	Negation 33 36	not
E1001	Negation:T1002 Scope:T1003
T1003	Span 33 100	not cut specific sites in the IRF-4 promoter in hematopoietic cells
T1004	Negation 536 538	no
E1002	Negation:T1004 Scope:T1005
T1005	Span 536 581	no recognition site within the IRF-4 promoter
T1006	Speculation 270 275	would
E1003	Speculation:T1006 Scope:T1007
T1007	Span 250 339	only methylated DNA would not be cut enabling subsequent PCR amplification and vice versa
T1008	Negation 1214 1217	not
E1004	Negation:T1008 Scope:T1009
T1009	Span 1214 1238	not a Bsh1236I digestion
T1010	Speculation 916 926	suggesting
E1005	Speculation:T1010 Scope:T1011
T1011	Span 916 1032	suggesting a promoter methylation (and restriction protection) at the respective recognition sites (Figure 3B and C)
T1012	Speculation 1372 1379	implied
E1006	Speculation:T1012 Scope:T1013
T1013	Span 1372 1561	implied that IRF-4 transcription in SD-1 and BV-173 cells is associated with less promoter methylation (in BV-173 especially at HpaII sites) as compared with the tested IRF-4-negative cells
T1014	Negation 1341 1344	not
E1007	Negation:T1014 Scope:T1015
T1015	Span 1317 1353	amplification of F1 was not affected
